1
项与 BCMA/CD19 dual-target CAR 相关的临床试验 / Not yet recruiting早期临床1期IIT An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies
This is a single center, single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability, preliminary efficacy and immunogenicity of OriV508 injection for patients with relapsed/refractory hematological malignancies.
100 项与 BCMA/CD19 dual-target CAR 相关的临床结果
100 项与 BCMA/CD19 dual-target CAR 相关的转化医学
100 项与 BCMA/CD19 dual-target CAR 相关的专利(医药)
100 项与 BCMA/CD19 dual-target CAR 相关的药物交易